• Issue

    British Journal of Haematology: Volume 173, Issue 2

    171-328
    April 2016
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

Issue Information

Free Access

Issue Information - Editorial Board

  • Page: 171
  • First Published: 13 April 2016
Free Access

Issue Information - TOC1

  • Page: 173
  • First Published: 13 April 2016
Free Access

Issue Information - TOC2

  • Page: 175
  • First Published: 13 April 2016
Free Access

Issue Information - Papers to be published in forthcoming issues

  • Page: 176
  • First Published: 13 April 2016

Images in Haematology

Metastatic lobular breast cancer diagnosed from a blood film

Lisa Clarke,  Carol Cheung, 
  • Page: 177
  • First Published: 21 December 2015

A case of Stage IA classical Hodgkin lymphoma with FDG-avid tonsils

Theodora Vatopoulou,  Charles Lawson,  Christopher Pocock, 
  • Page: 178
  • First Published: 12 February 2016

Reviews

How to manage lung infiltrates in adults suffering from haematological malignancies outside allogeneic haematopoietic stem cell transplantation

Georg Maschmeyer,  J. Peter Donnelly, 
  • Pages: 179-189
  • First Published: 05 January 2016

Advances in understanding the pathogenesis of graft-versus-host disease

John Magenau,  Lyndsey Runaas,  Pavan Reddy, 
  • Pages: 190-205
  • First Published: 27 March 2016

Advances in understanding erythropoiesis: evolving perspectives

Satish K. Nandakumar,  Jacob C. Ulirsch,  Vijay G. Sankaran, 
  • Pages: 206-218
  • First Published: 05 February 2016

Haematological Malignancy

CD45RA, a specific marker for leukaemia stem cell sub-populations in acute myeloid leukaemia

Bas Kersten,  Matthijs Valkering,  Rolf Wouters,  Rosa van Amerongen,  Diana Hanekamp,  Zinia Kwidama,  Peter Valk,  Gert Ossenkoppele,  Wendelien Zeijlemaker,  Gertjan Kaspers,  Jacqueline Cloos,  Gerrit J. Schuurhuis, 
  • Pages: 219-235
  • First Published: 27 January 2016

No survival benefit associated with routine surveillance imaging for Hodgkin lymphoma in first remission: a Danish-Swedish population-based observational study

Lasse H. Jakobsen,  Martin Hutchings,  Peter de Nully Brown,  Johan Linderoth,  Karen J. Mylam,  Daniel Molin,  Hans E. Johnsen,  Martin Bøgsted,  Mats Jerkeman,  Tarec C. El-Galaly, 
  • Pages: 236-244
  • First Published: 05 February 2016

Lenalidomide in combination with R-ESHAP in patients with relapsed or refractory diffuse large B-cell lymphoma: a phase 1b study from GELTAMO group

Alejandro Martín,  Alba M. Redondo,  Iván Dlouhy,  Antonio Salar,  Eva González-Barca,  Miguel Canales,  Santiago Montes-Moreno,  Enrique M. Ocio,  Armando López-Guillermo,  Dolores Caballero, on behalf of the Grupo Español de Linfomas y Trasplante Autólogo de Médula Ósea (GELTAMO) , 
  • Pages: 245-252
  • First Published: 05 February 2016

A phase 1, open-label, dose-escalation study of pralatrexate in combination with bortezomib in patients with relapsed/refractory multiple myeloma

Tamara J. Dunn,  Shira Dinner,  Elizabeth Price,  Steven E. Coutré,  Jason Gotlib,  Ying Hao,  Caroline Berube,  Bruno C. Medeiros,  Michaela Liedtke, 
  • Pages: 253-259
  • First Published: 04 April 2016

The potential benefit of allogeneic over autologous transplantation in patients with very early relapsed and refractory follicular lymphoma with prior remission duration of ≤12 months

Matthew A. Lunning,  Jocelyn C. Migliacci,  Patrick Hilden,  Sean M. Devlin,  Hugo Castro-Malaspina,  Sergio Giralt,  Miguel-Angel Perales,  Andrew D. Zelenetz,  Craig H. Moskowitz,  Craig S. Sauter, 
  • Pages: 260-264
  • First Published: 05 February 2016

Genes encoding members of the JAK-STAT pathway or epigenetic regulators are recurrently mutated in T-cell prolymphocytic leukaemia

Cristina López,  Anke K. Bergmann,  Ulrike Paul,  Eva M. Murga Penas,  Inga Nagel,  Matthew J. Betts,  Patricia Johansson,  Matthias Ritgen,  Tycho Baumann,  Marta Aymerich,  Sandrine Jayne,  Robert B. Russell,  Elias Campo,  Martin JS Dyer,  Jan Dürig,  Reiner Siebert, 
  • Pages: 265-273
  • First Published: 25 February 2016

Short duration immunochemotherapy followed by radioimmunotherapy consolidation is effective and well tolerated in relapsed follicular lymphoma: 5-year results from a UK National Cancer Research Institute Lymphoma Group study

Tim M. Illidge,  Hayley S. McKenzie,  Sam Mayes,  Andrew Bates,  Andrew J. Davies,  Ruth Pettengell,  Louise Stanton,  Kelly Cozens,  Grace Hampson,  Caroline Dive,  Maureen Zivanovic,  Jill Tipping,  Eve Gallop-Evans,  John A. Radford,  Peter W.M. Johnson, 
  • Pages: 274-282
  • First Published: 05 February 2016

Bendamustine + rituximab chemoimmunotherapy and maintenance lenalidomide in relapsed, refractory chronic lymphocytic leukaemia and small lymphocytic lymphoma: A Wisconsin Oncology Network Study

Julie E. Chang,  Thomas Havighurst,  KyungMann Kim,  Jens Eickhoff,  Anne M. Traynor,  Rachel Kirby-Slimp,  Lynn M. Volk,  Jae Werndli,  Ronald S. Go,  Matthias Weiss,  Jules Blank,  Brad S. Kahl, 
  • Pages: 283-291
  • First Published: 23 February 2016

Paediatrics

Predictors of early death and survival among children, adolescents and young adults with acute myeloid leukaemia in California, 1988–2011: a population-based study

Renata Abrahão,  Ruth H. Keogh,  Daphne Y. Lichtensztajn,  Rafael Marcos-Gragera,  Bruno C. Medeiros,  Michel P. Coleman,  Raul C. Ribeiro,  Theresa H. M. Keegan, 
  • Pages: 292-302
  • First Published: 05 February 2016

Platelets, Haemostasis and Thrombosis

Hoxa10 null animals exhibit reduced platelet biogenesis

Iwona M. Konieczna,  Teresa A. DeLuca,  Elizabeth A. Eklund,  William M. Miller, 
  • Pages: 303-313
  • First Published: 05 February 2016

Correspondence

Free Access

Heavy menstrual bleeding on rivaroxaban

Melanie Ferreira,  Sarah Barsam,  Jignesh P. Patel,  Julia Czuprynska,  Lara N. Roberts,  Raj K. Patel,  Roopen Arya, 
  • Pages: 314-315
  • First Published: 27 July 2015
Free Access

Monoclonal B-cell lymphocytosis and hypogammaglobulinaemia

Erica Glancy,  Roxana Siles, 
  • Pages: 316-317
  • First Published: 20 July 2015
Free Access

Long non-coding RNAs: biomarkers for acute leukaemia subtypes

Carolina P. de Souza Melo,  Catharina B. Campos,  Juliana de Oliveira Rodrigues,  Joaquim C. Aguirre-Neto,  Ângelo Atalla,  Mara A. D. Pianovski,  Edna K. Carbone,  Luciana B. Q. Lares,  Hélio Moraes-Souza,  Shirlei Octacílio-Silva,  Fabiano S. M. Pais,  Alessandro C. de Souza Ferreira,  Juliana G. Assumpção, 
  • Pages: 318-320
  • First Published: 23 July 2015
Free Access

Higher interleukin 21 level is predictive of relapse in immune thrombocytopenia. Is it associated with activation of the complement system?

Birsen Sahip,  Gulsum E. Pamuk,  Mehmet S. Uyanik,  Omer N. Pamuk, 
  • Pages: 321-323
  • First Published: 20 July 2015
Free Access

The importance of plasma D-2HG measurement in screening for IDH mutations in acute myeloid leukaemia

Elizabeth McGehee,  Dinesh Rakheja,  Dwight Oliver,  Weina Chen,  Richard Boriack,  Robert H. Collins Jr, 
  • Pages: 323-326
  • First Published: 20 July 2015
Free Access

Autoimmune haemolytic anaemia occurring during ibrutinib therapy for chronic lymphocytic leukaemia

Tom G. Rider,  Richard J. Grace,  Joel A. Newman, 
  • Pages: 326-327
  • First Published: 20 July 2015
Free Access

Autoimmune haemolytic anaemia occurring during ibrutinib therapy for chronic lymphocytic leukaemia – response to Rider et al

Alexey V. Danilov, 
  • Pages: 327-328
  • First Published: 20 July 2015